Diabetes screening study finds no reduction in mortality rates

October 3, 2012

The randomised trial, which is the first ever study evaluating the effect of type 2 diabetes screening programmes on overall mortality rates in a population, assessed the number of deaths over ten years in a group of more than 20 000 patients across 32 general practices in Eastern England. The patients were all aged between 40 and 69 years, and were assessed as being at high risk of diabetes.

Researchers allocated the practices participating in the trial to one of three groups: a group where one round of screening was followed up by routine care for patients diagnosed with diabetes; a group where one round of screening was followed up by intensive management of patients diagnosed with diabetes; and a control group where no screening took place. They then tracked mortality rates in the patients studied over a period of 9.6 years on average (median).

The authors of the study found that overall mortality was not reduced in the groups where screening took place. They also found no significant difference between the screened and non-screened groups in the number of deaths specifically attributable to diabetes, cardiovascular illness, cancer, or other causes of death.

According to Dr Simon Griffin, of the MRC Epidemiology Unit at Addenbrooke's Hospital in Cambridge, UK, "The high proportion of undiagnosed cases of diabetes, the substantial number of patients with complications at clinical diagnosis, and the long latent phase of the disease are strong arguments for screening. However, in the large UK sample that we studied, screening for type 2 diabetes in patients at increased risk of the disease was not associated with any reduction in mortality within ten years."*

"It seems that the benefits of screening might be smaller than expected and restricted to individuals with detectable disease. However, benefits to the population could be increased by including the detection and management of cardiovascular risk factors alongside the assessment of diabetes risk, performing repeated rounds of screening, and improving strategies to maximise the uptake of screening."*

The authors point out that despite the large sample size, their study has a number of limitations, including the fact that the study took place in an area of the UK of above-average affluence, and they warn that particular caution should be exercised in extrapolating the results to more socially disadvantaged communities, where the disease risk may be higher and attendance for screening is likely to be lower.

In a linked Comment, Michael Engelgau of the Centers for Disease Control and Prevention in Atlanta, Georgia, USA, writes, "Diabetes screening and diagnosis can be done with relative ease, which further escalates popular support for wide-scale screening. However, these compelling arguments overlook the screening costs, potential harms, and lack of clear evidence that screening improves health outcomes compared with current routine clinical diagnosis."

"This study increases the doubt about the value of wide-scale screening for undiagnosed diabetes alone, and deserves credit for tackling the screening quandary head-on. Nevertheless, for any one study to address the diverse factors that affect screening policies—ranging from the magnitude of population burden of disease to the capacity and effectiveness of prevention approaches—is a tall order. Screening recommendations are therefore likely to be country specific and context-specific for the foreseeable future."

Explore further: Study finds mammography screening reduces breast cancer mortality

More information: Study online: www.thelancet.com/journals/lan … (12)61422-6/abstract

Related Stories

Study finds mammography screening reduces breast cancer mortality

June 28, 2011
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal ...

PSA screening to detect prostate cancer can be beneficial to younger and at-risk men: study

May 7, 2012
Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal).

Study reveals optimal interval for stomach cancer screening

July 16, 2012
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the ...

Diabetic retinopathy research could reduce screening costs

May 7, 2012
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet ...

Recommended for you

Personalized blood sugar goals can save diabetes patients thousands

December 11, 2017
A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health ...

Kidney disease increases risk of diabetes, study shows

December 11, 2017
Diabetes is known to increase a person's risk of kidney disease. Now, a new study from Washington University School of Medicine in St. Louis suggests that the converse also is true: Kidney dysfunction increases the risk of ...

Type 2 diabetes is not for life

December 5, 2017
Almost half of the patients with Type 2 diabetes supported by their GPs on a weight loss programme were able to reverse their diabetes in a year, a study has found.

Skipping breakfast disrupts 'clock genes' that regulate body weight

November 30, 2017
Irregular eating habits such as skipping breakfast are often associated with obesity, type 2 diabetes, hypertension and cardiovascular disease, but the precise impact of meal times on the body's internal clock has been less ...

Type 2 diabetes has hepatic origins

November 28, 2017
Affecting as many as 650 million people worldwide, obesity has become one of the most serious global health issues. Among its detrimental effects, it increases the risk of developing metabolic conditions, and primarily type ...

Critical link between obesity and diabetes has been identified

November 28, 2017
UT Southwestern researchers have identified a major mechanism by which obesity causes type 2 diabetes, which is a common complication of being overweight that afflicts more than 30 million Americans and over 400 million ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.